Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Buy
2,188
+122
+6% +$41.8K 0.01% 147
2026
Q1
$727K Buy
2,066
+523
+34% +$186K 0.01% 130
2025
Q4
$528K Buy
1,543
+640
+71% +$203K 0.01% 147
2025
Q3
$255K Sell
903
-63
-7% -$18.3K 0.01% 187
2025
Q2
$285K Buy
966
+232
+32% +$65.7K 0.01% 139
2025
Q1
$206K Sell
734
-12
-2% -$3.54K 0.01% 135
2024
Q4
$219K Sell
746
-41
-5% -$12.2K 0.01% 136
2024
Q3
$251K Buy
787
+12
+2% +$3.92K 0.01% 122
2024
Q2
$258K Buy
775
+100
+15% +$29.4K 0.01% 114
2024
Q1
$202K Buy
+675
New +$198K 0.01% 121

Other funds holding AMGN

Facet Wealth Inc's AMGN Position: Q2 2026 in Review

Facet Wealth Inc increased its Amgen (AMGN) stake by 5.9% in Q2 2026, buying an estimated $41.8K and bringing the position to 2,188 shares worth $792K. The position accounts for 0.01% of the portfolio, ranked #147.

Facet Wealth Inc first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Facet Wealth Inc held 2,188 shares of Amgen worth $792K as of Q2 2026.
  • Facet Wealth Inc bought 122 Amgen shares in Q2 2026, an estimated $41.8K.
  • Amgen made up 0.01% of Facet Wealth Inc's portfolio in Q2 2026, its #147 holding.
  • Facet Wealth Inc first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.